Neonorm Dog extends Jaguar's existing Neonorm product franchise beyond foals and calves to provide dog owners with ...
Jaguar Animal Health, which is developing an animal formulation of its parent's approved diarrhea treatment, raised $20 million by offering 2.86 million shares at $7, the low end of its originally ...
Company's Canalevia ®-CA1 (crofelemer delayed-release tablets) prescription drug is FDA conditionally approved for treatment of chemotherapy-induced diarrhea (CID) in dogs and is the first and only ...
In May of 2015, Jaguar Animal Health ($JAGX) was spun out of Silicon Valley’s Napo Pharmaceuticals with hopes of capitalizing on Wall Street’s enthusiasm for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results